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A B S T R A C T
Introduction: Phthalates, a group of ubiquitous industrial chemicals, have been widely used in occupational
settings, mainly as plasticizers in a variety of applications. Occupational exposure to different phthalates has
been studied in several occupational settings using human biomonitoring (HBM).
Aim: To provide a comprehensive review of the available literature on occupational exposure to phthalates
assessed using HBM and to determine future data needs on the topic as part of the HBM4EU project.
Methods: A systematic search was carried out in the databases of Pubmed, Scopus, and Web of Science for
articles published between 2000 and September 4, 2019 using the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines. A total of 22 studies on the occupational HBM of phthalates
was considered suitable for review.
Results and discussion: Among the reviewed studies, 19 (86%) focused on DEHP, an old phthalate that is now
subject to authorization and planned to be restricted in the EU. Concentrations of MEHHP, one of its metabolites,
varied up to 13-fold between studies and across sectors when comparing extreme geometric means, ranging from
11.6 (similar to the general populations) to 151 μg/g creatinine. Only 2 studies focused on newer phthalates such
as DiNP and DPHP. Concerning the geographical distribution, 10 studies were performed in Europe (including 6
in Slovakia), 8 in Asia, and 4 in North America, but this distribution is not a good reflection of phthalate
production and usage levels worldwide. Most HBM studies were performed in the context of PVC product
manufacturing. Future studies should focus on: i) a more uniform approach to sampling timing to facilitate
comparisons between studies; ii) newer phthalates; and iii) old phthalates in waste management or recycling.
Conclusion: Our findings highlight the lack of recent occupational HBM studies on both old and new phthalate
exposure in European countries and the need for a harmonized approach. Considering the important policy
actions taken in Europe regarding phthalates, it seems relevant to evaluate the impact of these actions on ex-
posure levels and health risks for workers.
1. Introduction
Phthalates (also known as phthalate esters or esters of phthalic acid)
are a group of plasticizers with a worldwide production volume of
around 5.5 million tons per year (OECD, 2018). This family of
chemicals is widely used to soften plastics and has a strong performance
in terms of durability and stability. Although regulatory restrictions
have decreased exposure to old phthalates known as endocrine dis-
ruptors, workers in the plastics industry may still be exposed to newer
phthalates and phthalate substitutes. In this review, the term “newer
https://doi.org/10.1016/j.ijheh.2020.113548
Received 15 January 2020; Received in revised form 8 April 2020; Accepted 22 April 2020
∗ Corresponding author. SpFrance, Department of Environmental and Occupational Health (DSET), 12 rue du Val d’Osne, Saint Maurice cedex, 94415, France.
E-mail address: nadine.frery@santepubliquefrance.fr (N. Fréry).
International Journal of Hygiene and Environmental Health 229 (2020) 113548
1438-4639/ © 2020 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
phthalate” signifies phthalates that have substituted di(2-ethylhexyl)
phthalate (DEHP). They are not necessarily “new,” since many have
been used for more than 10 years. With regard to occupational ex-
posure, there are only limited data on the exposure of workers to dif-
ferent phthalates. Since phthalates usually have a low vapor pressure,
inhalation is often not the dominant route of uptake; oral (e.g., hands-
to-mouth transfer) and dermal routes can thus play an important role in
the total exposure. Therefore, human biomonitoring (HBM) is the most
relevant tool to estimate workers’ total exposure to phthalates, re-
gardless of the route of exposure.
An understanding of the various phthalates, their metabolism, dis-
tribution, and elimination kinetics is important for identifying valuable
biomarkers of exposure. Phthalates such as DEHP, DiNP, DiDP, and
DPHP (the definitions of abbreviations are provided in Table 1), which
are made of alcohols with long alkyl chains and defined as high mo-
lecular weight (HMW) phthalates, are mainly used to make polyvinyl
chloride (PVC) more flexible in various applications. The different
phthalates are summarized in Table 1. Those with shorter chains (or
aryl rings, low molecular weight (LMW) phthalates) such as DBP, DiBP,
BBzP, DEP, and DMP are mainly used in non-PVC products such as
personal care products and cosmetics (e.g., fragrances, skin lotions, nail
polish, eye shadows), textiles, paints, pesticides, lubricants, and ad-
hesives (Koch and Angerer, 2012). In the past, the most widely used
phthalates were DEHP, BBzP, DMP, and DEP, whereas DEHP was the
dominant plasticizer used globally in PVC (Wormuth et al., 2006) Ac-
cording to the available data, the time trend for the production volume
of phthalates has declined worldwide (i.e., more than 8 million tons in
2011, between 6 and 8 million tons in 2015, and 5.5 million tons in
2018), thus highlighting the decrease in occupational exposure to these
chemicals (Net et al., 2015; OECD, 2018; Wang et al., 2019).
Occupational exposure can take place by the dermal route (with low
molecular weight phthalates such as DEP, DBP, and BBzP) (Cavallari
et al., 2015), by inhalation (with more volatile phthalates like DEP and
DMP), or to a less extent, by ingestion (especially with the high mole-
cular weight DEHP and DINP). Human data on uptake after inhalation
exposure, ingestion, or dermal contact are generally limited. Some
studies suggest that phthalates are well absorbed from the gastro-
intestinal tract: for example, absorption of DEHP was shown to be more
than 50% and that of DBP around 80% in humans (Anderson et al.,
2011; Koch et al., 2005; Koch et al., 2012a; Seckin et al., 2009).
Following exposure and uptake, phthalates are rapidly metabolized,
and both the conjugated and the free (non-conjugated) phthalate me-
tabolites are excreted in urine and partly in feces (Silva et al., 2003).
The relatively polar and short-chain phthalates such as DMP, DEP, DBP,
and DiBP are rapidly hydrolyzed to monoesters and eliminated mainly
as free monoesters and glucuronide conjugates. Long-chain phthalates
such as DEHP, DiNP, and DPHP metabolize to their monoesters, which
are extensively transformed to secondary oxidized metabolites.
Phthalates have short biological half-lives and are quickly excreted
from the body. For long-chain phthalates, the elimination of oxidized
metabolites is predominant, followed by monoesters. For shorter-
chained phthalates (DEP, DBP, DiBP, BBzP), approximately 70–80% of
Table 1
Phthalates and their urinary metabolites together with 24-h molar excretion percentages of the metabolites.
Phthalates Systematic name CAS No Abbreviation/Acronym Primary
metabolite
Molar % excreted in
24 h
Secondary metabolite Molar % excreted in
24 h
Ref
Low molecular weight (LMW) phthalates
Dimethyl phthalate 131-11-3 DMP MBP n.a. – –
Diethyl phthalate 84-66-2 DEP MEP n.a.a – –
Di-n-butyl phthalate 84-74-2 DBP MBP 69; 78; 84 – – 3, 1, 2
3OH–MBP 6.9 2
MCPPb 0.5 2
Diisobutyl phthalate 84-69-5 DiBP MiBP 70.3 – – 2
2OH-MiBP 19.3 2
3OH-MiBP 0.7 2
Butyl benzyl phthalate 85-68-7 BBzP MBzP 73 – – 3
MBP 6 – – 3
High molecular weight (HMW) phthalates
Di(2-ethylhexyl) phthalate 117-81-7 DEHP MEHP 2.6; 6.2; 7.3 – – 4,5,6
MEHHP (or 5OH-MEHP) 13.3; 14.9; 24.1 4,5,6
MEOHP (or 5oxo-MEHP) 10.9; 14.6; 15.0 5,6,4
MECPP (or 5cx-MEPP) 13.2; 20.7 5, 7
Diisononyl phthalate 28553-12-0
68515-48-0
DiNP MiNP 3 – – 5
OH-MiNP 11.4; 18.4 5, 8
oxo-MiNP 6.3; 10.0 5, 8
cx-MiNP 9.9; 9.1 5, 8









References: 1: Seckin et al. (2009); 2: Koch et al. 2012a; 3: Anderson et al. (2001); 4: Kessler et al. (2012); 5: Anderson et al. (2011); 6: Koch et al. (2004); 7: Koch
et al. (2005); 8: Koch et al. (2017); 9: Wittassek and Angerer (2008); 10: Leng et al. (2014).
Other phthalates are not common in Europe: DOP, DPeP, DCHP, DiPP, DHNUP, DHP, DMEP.
a Sometimes set to be the same as that of DnBP (69%, Anderson et al., 2001).
b MCPP is also a metabolite of other phthalates (Calafat et al., 2006).
c Molar excretion percentages of DiDP metabolites are not available. Due to the similar molecular structure of DiDP and DPHP, it could be assumed that the molar
excretion percentages of their metabolites are close to each other; CAS No 26761-40-0 is no longer produced in Europe (Leng et al., 2014).
d Determined 61 h after exposure.
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an oral dose is excreted as the simple monoester metabolite in urine
compared to less than 10% and 3% of the long-chained phthalates
DEHP and DiNP, respectively (Anderson et al., 2001; Johns et al., 2015;
Koch and Angerer, 2007; Koch et al., 2003a, 2003b, 2012a, 2012b). The
elimination of phthalate metabolites often follows a multi-phase pat-
tern: for example, the elimination half-lives of OH-MiNP and oxo-MiNP
are about 12 h in the second phase compared to 18 h for cx-MiNP.
Indeed, after single oral doses of both DBP and DiBP in a human vo-
lunteer, the majority of the dose was excreted in the first 24 h, while
less than 1% was excreted in urine on day 2. For MBP, the monoester of
DBP, the final urinary elimination half-life was reported to be 2.6 h in
one subject but slightly longer for oxidized metabolites (Koch and
Angerer, 2012). Due to their kinetics, some phthalates such as DEHP,
DiNP, and DiDP have the potential to accumulate during the working
week in the case of daily exposure. For the occupational HBM of
phthalates, the concentration of the degradation products (metabolites)
is commonly analyzed in urine. The parent phthalates and their meta-
bolites are presented in Table 1.
Due to their ubiquitous nature, phthalate diesters are not commonly
measured in the biomonitoring of phthalate exposure (Koch et al.
2003b; Silva et al., 2007). Contamination by non-oxidized monoesters
may also occur for two reasons: first, phthalate additives in PVC are not
free of monoesters, and second, phthalates can hydrolyze to monoesters
in the environment (general and occupational). In fact, contamination
can occur during the collection, transportation, storage, and analytical
processes, while plastics in laboratory equipment can also contain
phthalates. Consequently, urinary metabolites (monoesters, and in the
case of high molecular weight phthalates, preferably secondary oxi-
dized metabolites) are usually used as biomarkers to assess phthalate
exposure, because the type of matrix used in biomonitoring studies is
urine, and in this type of sample, the result of the metabolism and not
the original compounds will essentially be found (Latini, 2005;
Townsend et al., 2013; Yoshida, 2017).
Many phthalates are shown to cause reproductive toxicity in ani-
mals. These effects are mediated by their anti-androgenic properties.
Some of them (C3–C6 side chains) induce the so-called phthalate syn-
drome in rats, which covers different reproductive abnormalities in the
male offspring of rats exposed during pregnancy. The most potent re-
presentative is DPeP, followed by DEHP, DBP, DiBP, BBzP, and DCHP
with comparable potency (Gennings et al., 2014). DiNP has a somewhat
lower potency as an anti-androgen, while there is no evidence of anti-
androgenic activity in DiDP and DPHP (Bhat et al., 2014; Furr et al.,
2014). In humans, some studies describe the association between ad-
verse male reproductive effects (effects on anogenital distance, semen
parameters, testosterone levels, time to pregnancy) and phthalates,
especially DEHP and DBP (Radke et al., 2018). Mixtures of anti-an-
drogenically active phthalates are likely to have dose additive effects,
which was taken into account in recent risk assessments of these
phthalates (ECHA, 2012, 2017/RAC opinion on phthalate restriction).
Exposure to phthalates has been suggested to cause other effects such as
immunotoxicity (increased risk of asthma and allergies), neurodeve-
lopmental effects, and metabolic effects (obesity; Wang et al., 2019).
Data on these associations are nevertheless weaker than those on re-
productive effects and are not sufficient for the risk assessment of
phthalates (ECHA, 2017).
Due to their classification as reproductive toxicants in category 1 B
under Annex VI to the Classification Labelling and Packaging (CLP)
regulation, DEHP, DBP, DiBP, and BBzP have been added to the list of
substances of very high concern (Annex XIV EC, 1907/2006) in the EU
and subjected to authorization under the Registration, Evaluation,
Authorization, and Restriction of Chemicals (REACH) regulation.
Furthermore, DPeP, DiPP, DHNUP, DHP, and DMEP are on the candi-
date list of substances of very high concern for authorization (i.e., SVHC
candidates) due to the same toxicological properties. The most recent
restriction of phthalates concerns articles containing DEHP, DBP, DiBP,
and BBzP in a concentration greater than or equal to 0.1% (individually
or in combination) on the market in the EU. This proposed restriction
was supported by socioeconomic and risk assessment committees (SEAC
and RAC) of the European Chemical Agency (ECHA) in 2017 and is
currently waiting for adoption by the Commission. Under the EU oc-
cupational safety and health legislation, no EU-wide occupational gui-
dance values have been set for phthalates, but the current re-
commendations of the Scientific Committee on Occupational Exposure
Limits (SCOEL) with respect to DBP propose an occupational exposure
limit of 0.58 mg/m3 (0.05 ppm) as an 8-h time-weighted average. No
biological limit value for occupational exposure is available at the
European level. However, Germany and France have established their
own biological limit values. Besides the German Research Foundation's
(Deutsche Forschungsgemeinschaft, DFG) BAT value for DEHP (4 mg
∑(MEHP+5OH-MEHP+5oxo-MEHP+5cx-MEPP)/g creatinine [cr])
(Rettenmeier et al., 2019), French biological limit values have been
established for: i) DBP (urinary MBP of 70 μg/L or 50 μg/g cr), ii) BBzP
(urinary MBzP of 40 μg/L or 30 μg/g cr), and iii) DEHP (urinary 5cx-
MEPP of 200 μg/g cr regardless of smoking status) (ANSES website).
Biomonitoring equivalent values in urine, defined as the con-
centrations or range of concentrations of the metabolite in a biological
matrix corresponding to an external health-based reference dose (RfD)
or tolerable daily intake (TDI), have been derived for certain phthalate
metabolites to be used as screening tools for the evaluation of general
population biomonitoring data (Aylward et al., 2009a, 2009b; Hays
et al., 2011). Also, the German Human Biomonitoring (HBM) Com-
mission has provided some health-related guidance values for the
general population (HBM assessment values – HBM values), mainly on
the basis of internationally agreed TDI/RfD values for some phthalates:
HBM I values (i.e., concentration of a substance in human biological
material at or below which there is no risk of adverse health effects
based on the current knowledge and assessment of the HBM Commis-
sion) for the sum of DPHP metabolites, oxo-MPHP, and OH-MPHP, as
well as for the DEHTP metabolite 5cx-MEPTP in urine (Apel et al.,
2017).
In the framework of the EU HBM initiative known as HBM4EU
(www.hbm4eu.eu), a state-of-the-art review of occupational HBM data
on phthalate exposure was performed. The aim of this review was to
identify the industry fields/work tasks that may result in the highest
exposure to phthalates. In addition, we provide an overview of avail-
able knowledge on occupational HBM of phthalate exposure, with
particular attention given to the following: i) the specific biomarkers
used (old and newer phthalates); ii) the (current) biomonitoring levels
of workers in different occupational settings; iii) the observed links
between biomarkers of exposure and health effects; and iv) the future
needs in occupational HBM of phthalates in Europe.
2. Methods
According to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines, a systematic search was car-
ried out in the databases of PubMed, Scopus, and Web of Science for
articles published between 2000 and September 4, 2019. Initial search
terms were developed to identify studies in occupational settings that
use HBM of phthalates (metabolites) as well as HBM studies/surveil-
lance programs that incorporate the monitoring of phthalate exposure.
One search strategy was developed and adapted to each database
(PubMed, Scopus, and Web of Science). In the databases, we used a
combination of free text terms, and the search strategy was developed
with low specificity to the advantage of high sensitivity: broad search
terms included phthalate, workplace, worker, and occupation. No re-
strictions regarding language or publication type (articles or reviews)
were applied in this phase. This search strategy led to 201 PubMed
papers, 271 Scopus papers, and 256 Web of Science papers.
The titles and abstracts of all references were retrieved after re-
moving duplicates. They were independently screened in parallel by 2
members of the project team with respect to the inclusion/exclusion
N. Fréry, et al. International Journal of Hygiene and Environmental Health 229 (2020) 113548
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criteria. Articles that did not meet the inclusion criteria (see below)
were excluded from further analysis, although a few are cited in the
discussion. The 2 reviewers compared findings for consistency with the
aim to highlight any discrepancies and define an agreed final set of
papers to be analyzed. All the abstracts were reviewed and classified
according to different categories (occupational HBM data on phthalate
exposure, analytical methods, toxicological studies, not on the topic,
not in English, occupational exposure study without HBM, HBM in the
general population, review, HBM with effect biomarkers), and the final
set of studies was decided (Fig. 1). Congress abstracts, studies on cel-
lular and animal models, genotoxicity studies, and HBM studies fo-
cusing on the general population instead of occupational exposure were
excluded except if occupational exposure was considered.
We included occupational HBM studies performed in different ac-
tivity sectors, on old and new phthalates, and in different countries
(Europe, Asia, and North America). Cross-sectional, longitudinal/co-
hort, and case-control studies were considered. There was no limit to
the number of subjects included in the study; thus, the power of sta-
tistics was not used as criteria.
The sampling method could be random, convenience/intentional, or
stratified, although intentional sampling is often the case in occupa-
tional HBM. The primary outcome was the reporting of occupational
exposure measured as the mean/median concentration of phthalates in
the different groups of exposure. Studies on analytical methods and new
biomarkers were also included. Fig. 1 describes the different phases of
the selection of papers.
Full papers were obtained for the 47 selected studies, and at the
minimum, abstracts were available for the excluded papers that could
be used for the discussion (see References); 22 occupational HBM stu-
dies on phthalate exposure and 25 on analytical methods were identi-
fied. A critical qualitative analysis of the available studies was per-
formed to identify the strengths and limitations of the investigations.
Relevant issues analyzed included: the study population (size of the
target population, subgroups, inclusion criteria/sampling strategy,
sample size); chemicals under investigation; studied biomarkers and
matrix; sampling strategy (specificity and sensitivity of biomarkers,
sampling timing); and applied analytical methods (quality assurance/
limit of detection [LOD]-limit of quantification [LOQ], contamination,
matrix adjustment, sampling strategies). These topics were adapted
from the criteria commonly employed to assess the quality of non-
persistent biomarker studies (e.g., LaKind score criteria, LaKind et al.,
2014), although a quantitative quality assessment and tiering approach
could not be applicable due to the complexity of the reviewed phthalate
investigations (i.e., the large number of phthalates analyzed in each
study). Moreover, we were unable to highlight the relationships be-
tween the available biomonitoring data and the operating conditions, as
well as the risk management measures adopted in the studied sectors, as
most of the studies lacked or did not provide sufficient details to un-
derstand their influence on the results.
Sixteen documents (gray literature) on phthalates were also iden-
tified from national agencies in Europe (European Plasticisers, 2018;
ECHA, 2019) and North America, the International Agency for Research
on Cancer (IARC, 2013), and the Scientific Committee on Occupational
Exposure Limits in Europe (EC/SCOEL 2017), including 6 documents
from France (3 from the French Agency for Food, Environmental and
Occupational Health & Safety (ANSES, 2011, 2013; ANSES et al., 2015),
1 from the National Research and Safety Institute (INRS, 2017), and 2
from the Public Health France (Dereumeaux et al., 2016; SpFrance,
2019)), 1 from Finland (Finnish Institute of Occupational Health; Porras
et al., 2016), 1 from Sweden (Institutet för Kemisk Analys Norden;
IFKAN, 2010), 2 from Germany (German Environment Agency
(Rettenmeier et al., 2019) and Wuppertal Institut für Klima et al.,
2015), 2 from the USA (Centers for Disease Control and Prevention;
CDC 2013; 2019), and 1 from Canada (Health Canada, 2013). Seven of
Fig. 1. Different phases of the selection process.
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them were in English, while the remainder were in French, German,
and Finnish. Seven focused on occupational exposure, while the others
related to the general population.
3. Results
Several topics are addressed in this review of occupational HBM
studies on phthalate exposure: i) the availability of HBM data on old
and new phthalates and their levels; ii) the analytical methods em-
ployed to determine phthalate metabolite concentrations; iii) the
countries involved in HBM studies; iv) the strengths and limitations of
the reviewed HBM studies according to the countries in which they
were performed; v) biomonitoring levels; vi) the occupational settings
under investigation; vii) sex-related characteristics; and viii) any asso-
ciations observed with health effects.
3.1. Studied phthalates in HBM studies on occupational exposure
Table 2 presents the HBM studies on occupational phthalate ex-
posure. Most of the studies present urinary data on “old” phthalates,
which are no longer used in Europe or remain in limited use. DEHP was
analyzed in 19 out of 22 studies (86%), of which only 7 deal only with
DEHP exposure. Other old phthalates studied were DMP (4 studies),
DEP (10), DBP (11), DiBP (3), BBzP (4), and DOP (2). Occupational
exposure to “newer” phthalates such as DiNP, DiDP, and DPHP was
investigated much less frequently. Five studies were identified in which
DiNP exposure was evaluated (Hines et al., 2012; Koch et al., 2012;
Kolena et al., 2014; Petrovicova et al., 2014; Pilka et al., 2015), and in
one of them, workers were also co-exposed to DiDP or DPHP (Koch
et al. 2012b). No other occupational DiDP/DPHP studies were pub-
lished in international journals. Further, no occupational biomonitoring
studies exist for the other phthalates cited in Table 1 (DPeP, DCHP,
DiPP, DHP, DMEP), but as stated, they have either no use or a very
limited use in Europe. In the oldest phthalate study considered in this
review, Vermeulen et al. (2005) analyzed phthalic acid as a common
metabolite for several phthalates. The authors did not specify the
phthalates to which the rubber manufacturing workers who partici-
pated in the study were exposed. However, they stated that the most
common phthalates used at the time by the rubber industry were DBP
and diisooctyl phthalate (DiOP), while DEHP, DiBP, and diallyl
phthalate (DAP) were also employed.
3.2. Analytical methods used
Typically, total phthalate metabolite concentrations (free + con-
jugated) are measured. Thus, in sample pretreatment, glucuronyl-con-
jugated phthalate metabolites are transferred to their free forms after
enzymatic hydrolysis. Offline or online solid-phase extraction are the
most common extraction methods but liquid-liquid extraction is also
used. Liquid chromatography (LC) is the dominant separation method
in phthalate analytics, and occupational studies are no exception
(Table 2). However, gas chromatography (GC) can be used to separate
phthalate metabolites, although a derivatization step is needed, which
makes it slightly more time-consuming than LC analytics. The GC
method nevertheless offers some advantages over LC, especially in the
separation of secondary metabolites of high molecular weight phtha-
lates (Gries et al., 2012; Kumar and Sivaperumal, 2016). For example,
Gries et al. (2012) presented a GC-high-resolution mass spectrometry
(MS) method, which allows the specific determination of DPHP meta-
bolites in the presence of DiDP metabolites. Due to the lower separation
power, this is not possible with LC-MS/MS methods.
Typically, the LOD of the reported analytical methods ranges from
sub-μg/L to <5 μg/L for the different metabolites in human urine
samples (Kumar and Sivaperumal, 2016). This is also the case with most
of the occupational biomonitoring studies (Table 2).
3.3. Countries
Regarding the countries in which the investigations were per-
formed, from the 22 HBM studies considered in this review (Table 2), 8
were performed in Asia (3 in China: Lu et al., 2014; Pan et al., 2006,
Wang et al., 2018; 4 in Taiwan: Fong et al., 2014, 2015; Huang et al.,
2014, 2018; and 1 in Korea: Park et al., 2010; among the most recent), 4
in North America (Cavallari et al., 2015; Hines et al., 2009, 2012;
Kwapniewski et al., 2008) and 10 (45.5%) in Europe. The distribution
of occupational HBM studies in Europe was as follows: 6 studies in
Slovakia (Petrovicova et al., 2014, 2016; Pilka et al., 2015; Kolena
et al., 2014, 2017, 2019), 2 in France (Gaudin et al., 2008, 2011), 1 in
Germany (Koch et al. 2012b) and 1 in the Netherlands (Vermeulen
et al., 2005). The German study, however, was limited in size, while the
Dutch study used unspecific biomarkers for exposure assessment.
3.4. Strengths and limitations of the reviewed studies
3.4.1. Asian studies
The most recent Asian HBM studies used for this review were per-
formed in China and Taiwan (Huang et al., 2018; Wang et al., 2018).
Most of the 8 Asian papers (Lu et al., 2014; Pan et al., 2006; Wang et al.,
2018 in China; Fong et al., 2014, 2015; Huang et al., 2014, 2018 in
Taiwan) included more than 40 workers. A control group was not sys-
tematically included (Fong et al., 2015; Huang et al., 2018; Park et al.,
2010 in Korea). When included, however, controls were farmers (Wang
et al., 2018) or students (Huang et al., 2014), but in most cases, they
were workers from the same plant (such as administrative workers:
Huang et al., 2014; Lu et al., 2014). The possible occupational phthalate
exposure of control workers could not be excluded in all cases (e.g., la-
boratory workers, as phthalates are widely used in labs, Lu et al., 2014;
construction workers, Pan et al., 2006). In one study, no difference in
phthalate metabolite levels was observed between exposed workers and
controls (Lu et al., 2014), whereas in other studies, the median con-
centration of phthalates among workers was usually up to 5 times higher
than in controls. Analytical measurements were performed by LC/MS-
MS, and biomarkers were adjusted for creatinine. LODs were given ex-
cept in Lu et al. (2014). All measured phthalates were old phthalates
(DEHP, DEP, DBP, BBzP, DMP), and the measured biomarkers were
generally specific to the studied phthalates (e.g., MEHHP, MEOHP). An
exception was the study of Pan et al. (2006), which only measured MBP
and MEHP; MBP is not only a major metabolite of DBP but also a minor
metabolite of BBzP (6% of the dose; Anderson et al., 2001). Further,
MEHP is not a recommended biomarker, since DEHP can be hydrolyzed
outside the body (abiotically) to MEHP, and external contamination can
thus confound the results (as discussed by Hines et al., 2012 and Koch
et al. 2012b). Nevertheless, there is a lack of data on the importance of
this process. Another reason why MEHP is perhaps an inappropriate
biomarker is that it occurs at lower levels and is rapidly transformed to
secondary metabolites. In all these studies, spot urine samples were
collected both pre- and post-shift, except in Huang et al. (2014) and Lu
et al. (2014) where samples were collected only post-shift.
3.4.2. European studies
From the 10 European HBM studies on phthalates, the most recent
were from Slovakia (2014–2019). The sample sizes in the Slovakian
studies ranged from 30 to 82, which is a common sample size for an
occupational HBM study (Petrovicova et al., 2014, 2016; Pilka et al.,
2015; Kolena et al., 2014, 2017, 2019). In some cases, the timing of the
sampling was not appropriate for the studied biomarkers. For example,
in the studies of Kolena et al. (2017, 2019), the analyses were per-
formed in the first spot urine samples, collected the morning after a
workday (at the end of the workweek, i.e., Friday), which may not
correctly represent occupational exposure, because phthalates have
short half-lives, meaning that the morning phthalate levels may be less
elevated than those from the evening workday samples. No pre-shift
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samples were collected. In the studies of Petrovicova et al. (2014,
2016), Pilka et al. (2015), and Kolena et al. (2014), the biological
sampling was a single spot urinary sample collected during a work shift
break (between the start and the end of the workday) for exposed
workers; in this case, however, metabolite concentration peaks asso-
ciated with occupational exposure could occur later. Biomonitoring
results in exposed subjects were compared to a control group recruited
from students and general workers, except in the studies of Kolena et al.
(2014, 2019), which did not include a control group. Though carried
out in 2 different regions of Slovakia, the studies of Kolena et al. per-
formed in 2017 and 2019 were very similar. In all studies, the analytical
techniques using high-performance liquid chromatography and tandem
mass spectrometry (HPLC-MS/MS) had a high sensitivity, and LODs
were reported for all metabolites. Some of the measured biomarkers
corresponded to currently used phthalates (DiNP), but most were for
old phthalates (DEHP, DBP, DEP). No adjustments to creatinine or
specific gravity were made. Most of the measured biomarkers can be
considered specific for the studied phthalates, except MBP (also a minor
metabolite of BBzP; studied in all the Slovakian studies). As discussed
above, MEHP and MiNP assessed in these studies were perhaps not the
best choice for biomarkers, while the oxidized metabolites of DEHP and
DiNP were not studied. The sum of the different biomarkers was also
presented. The aim to detect associations between urinary phthalate
metabolite concentrations and i) occupation, ii) consumer practices,
and iii) body composition was somewhat ambitious in view of the
sample size of participants (lack of statistical power to study all the
parameters; Petrovicova et al., 2016, 80 workers and 49 controls).
Concerning the 2 French studies (Gaudin et al., 2008, 2011), they only
assessed DEHP exposure. The biomarkers used included 3 urinary meta-
bolites of DEHP, MEHP, and MECPP, and 2-ethylhexanoic acid (2-EHA), a
degradation product of DEHP. In both studies, the analytical performance
seemed appropriate: HPLC-MS/MS, LODs reported for all metabolites,
creatinine-adjusted biomarkers, an external quality control, and biological
sampling based on pre- and post-shift urinary spot samples collected over
5 days. The first study of Gaudin et al. (2008) aimed to test the biomarker
measurement (very small sample size of only 5 workers), while the second
study (Gaudin et al., 2011) applied this method to 6 PVC factories, with
simple group comparisons (62 workers and 29 controls).
The German study was rather an analytical approach to measure ex-
posure to DEHP, DiNP, and DiDP/DPHP and their metabolites (Koch et al.
2012b), since it was performed on only 5 workers and 10 controls from the
same plant. Single pre-shift (at the start of the workweek) and post-shift
urine samples were collected. The analytical method was performed using
HPLC-MS/MS, reported LODs, and creatinine-adjusted biomarkers.
The oldest European study reported in this review was conducted in
the Netherlands (Vermeulen et al., 2005). It assessed total phthalates
through a non-specific biomarker (urinary phthalic acid) in around 100
workers without a control group. It used LC-MS, and spot urine samples
were collected on Sunday, Tuesday, Wednesday, and Thursday at ap-
proximately the same time of the day.
3.4.3. North American studies
In the 4 North American HBM papers (Cavallari et al., 2015; Hines et al.,
2009, 2012; Kwapniewski et al., 2008), most of the studied biomarkers
corresponded to old phthalates (DEP, DBP, DEHP, DiBP, BBzP), except for
the study of Hines et al. (2012) (DiNP). In the earlier study of Hines et al.
(2009), the sample size exceeded 100 individuals, which provides a good
overview of the exposure in different sectors of the studied manufacturing
companies. No control group was included in these studies, although the
results were compared to the data from the general US population. Hines
et al. (2009, 2012) collected mid- and end-shift urine samples in a single
work shift on any day of the working week. Kwapniewski et al. (2008) and
Cavallari et al. (2015) collected pre- and post-shift samples, and in the latter
study, 4 samples per worker were collected at different moments during the
day (first void, before shift, end of shift, before bedtime). The analyses were
performed using HPLC-MS/MS; the studies reported LODs (most biomarker
concentrations were above the LODs), and biomarker concentrations were
adjusted for creatinine. Most of the measured biomarkers were specific,
except MBP in Hines et al. (2009) and Kwapniewski et al. (2008), and
MEHP in Cavallari et al. (2015). In addition, DiNP exposure assessment by
analyzing cx-MiNP can lead to some uncertainty, because cx-MiNP is not a
single compound but rather a mixture of several structural isomers (see
Hines et al., 2012).
3.5. Biomonitoring levels
Although various biomarkers of phthalates were studied in the re-
viewed papers, to compare results across studies, Table 3 presents the
data on MEHHP (or 5OH-MEHP), which is the main secondary meta-
bolite of DEHP. A variation in concentration levels up to about 13-fold
could be observed when comparing the lowest and highest geometric
means (GMs) in the different studies (GM of MEEHP: from 11.6 μg/g cr
in workers from flavoring factories in China to 151 μg/g cr in a PVC
film manufacture in the USA); most GMs of MEHHP were under 50 μg/g
cr. We noted that for some workers, the exposure could reach very high
values (max around 700 μg/g cr for MEHHP).
3.6. Occupational settings
Most HBM studies were performed in relation to the manufacturing
of PVC plastic products (12 papers); other sectors included waste
management (3), beauty (5, manicurists, hairdressers, and cosmetics
sales), cleaning (1), dental laboratory (1), and flavoring factory (1)
(Table 2). From the studies on MEHHP in Table 3, 18 work tasks can be
differentiated, most of which concern PVC plastics. There are limited
data on the use of newer phthalates in the manufacturing of different
plastic products and on exposure in the construction sector (e.g., in-
stallation/removal of PVC floorings). In addition, there are no data
from the use of phthalates in the cosmetics industry.
3.7. Sex-related characteristics
It was not possible to directly compare the exposure of male and fe-
male workers, since they were involved in different job tasks in the
available occupational studies. Since the majority of studies focused on the
plastics sector (industrial sector), it is not surprising that most data relate
to male workers. Nevertheless, 4 studies (Hines et al., 2009; Kolena et al.,
2017, 2019; Kwapniewski et al., 2008) focused on activities usually per-
formed by women (hairdressers and manicurists). In hairdressing ap-
prentices (Kolena et al., 2017), the median phthalate metabolite levels
were significantly higher than in controls for MiBP: median MiBP: 40.33 vs
24.20 μg/L, p ≤ 0.05; median for sum of DEHP metabolites (MEHP,
MEHHP, and MEOHP): 31.37 vs 26.94 μg/L; median MBP: 81.17 vs
73.85 μg/L in controls. Yet these concentrations were significantly lower
than those observed in the 2019 study of Kolena et al., which was also
performed in hairdressing apprentices but in another Slovakian region
(median MEHHP in Western (Kolena et al., 2017) vs Central Slovakia
(Kolena et al., 2019): 16.8 vs 27 μg/L, p ≤ 0.005; median MEOHP: 10.3 vs
14 μg/L, p ≤ 0.005; median sum of DEHP: 31.4 vs 45 μg/L, p ≤ 0.05).
However, since the samples were collected from the first morning voids on
the day after the workday, no far-reaching conclusions can be drawn from
these studies regarding occupational exposure (due to the short half-life of
phthalates). In the study of Kwapniewski et al. (2008), manicurists showed
significant cross-shift (post-pre) increases of 17.4 μg/L for MBP (median of
90 μg/L MBP post-shift) and 0.3 μg/L for mono-(3-carboxypropyl)
phthalate (MCPP), a minor metabolite of DBP (also a metabolite of other
phthalates; Calafat et al., 2006). In another American study, the exposure
in manicurists was relatively low but similar to those observed in workers
from PVC film or vehicle filter manufacturing companies (median MBP
around 30 μg/L) and lower than those seen in workers in phthalate
manufacturing in the rubber industry (MBP at mid-exposure 230 μg/L and
end-exposure around 1000 μg/L; Hines et al., 2009).
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3.8. Health effects in occupationally exposed subjects
Available HBM studies give insight into the major health effects of
phthalates but also open avenues for further investigation. Table 4
presents the HBM studies on occupational phthalate exposure in rela-
tion to the effect biomarkers and health indicators.
3.8.1. Hormones
Few biomonitoring studies evaluate the association between phthalate
levels and hormonal disturbances in workers. Workers at a factory pro-
ducing unfoamed PVC flooring had significantly higher concentrations of
MBP and MEHP as well as significantly lower levels of free testosterone
than unexposed workers (Pan et al., 2006). In this study, the difference in
phthalate levels between control and exposed workers was very clear: on
average, MEHP levels were approximately 100 times higher in exposed
workers than in controls (MBP: 644.3 vs 129.6 μg/g cr; MEHP: 565.7 vs
5.7 μg/g cr). In PVC production workers, a statistically significant positive
association was observed between urinary concentrations of DEHP meta-
bolites and estradiol, and the ratio of estradiol to testosterone (Fong et al.,
2015). No unexposed control group was included in this study. Park et al.
(2010) studied the association between sex hormone levels and phthalate
exposure in 25 workers from dental labs, but no association was observed.
On average, post-shift phthalate concentrations in urine were less than
twice their pre-shift levels, although the differences were statistically sig-
nificant (post-vs pre-shift GMs: 3.10 vs 2.23 μg/g cr for MEHP; 4.37 vs
3.54 μg/g cr for MEHHP and 3.40 vs 2.65 μg/g cr for MEOHP) (Park et al.,
2010). In China, workers engaged in waste plastic recycling had sig-
nificantly higher urinary concentrations of phthalate metabolites (MBzP,
MOP, MEHHP, MEP) and total triiodothyronine (T3) or T3/T4 (thyroxine)
ratio than controls. However, positive correlations between phthalate
metabolites and total T3 or T3/T4 ratio were observed among all parti-
cipants, not only exposed workers, except for urinary MBzP; in the ex-
posed group, only urinary MBzP was positively correlated with serum total
T3 (Wang et al., 2018).
3.8.2. Sperm quality
In a group of occupationally exposed PVC workers with elevated
DEHP metabolite levels (MEHP, MEHHP, MEOHP), Huang et al. (2014)
reported lower sperm concentration, reduced sperm motility, and in-
creased sperm reactive oxygen species (ROS) generation compared to
controls. However, the age and smoking status of exposed and control
groups significantly differed, as well as their alcohol consumption,
particularly in the high exposure group, which may have affected the
results. In addition, the number of persons in both control and low
exposure groups was very low. Therefore, it is not possible to draw
reliable conclusions based on this study.
3.8.3. Other health effects
Petrovicova et al. (2016) found an inverse correlation between urinary
MEHP levels and anthropometric parameters (waist-to-height ratio, body
mass index, waist-to-hip ratio, hip circumference, and waist circumference)
in female but not in male workers. The study included a control group as
well as workers from the plastic waste management and community service
sectors, with the highest exposures observed in plastic sectors.
In waste management workers, there was an association between
occupational urinary phthalate metabolites (MEHP, MiNP) and altera-
tions in pulmonary function parameters (Kolena et al., 2014), but it
may be speculated that other agents present in the working environ-
ment, which were not part of the study's analysis, could also contribute
to such a result. Among hairdressing apprentices, relationships between
urinary phthalate metabolites and spirometry values were observed;
negative associations were found between urinary MEHP, MEOHP,
MEHHP, sum of DEHP, and vital capacity, and also between MEHP or
MEOHP and forced vital capacity (Kolena et al., 2017, 2019). Also, in
this case, it should be noted that hairdressers are exposed to many other
substances that affect their respiratory health.
4. Discussion
Some critical issues emerging from the analysis of the HBM studies on
occupational phthalate exposure need to be considered for a suitable
interpretation of the results as well as for future investigations on the
topic. Overall, most of the reviewed occupational studies focused on the
biological monitoring of exposures to older phthalates whose use is
limited in Europe, although they are still expected in waste management
and recycling activities. The majority of investigations were performed in
Europe and Asia and were predominantly focused on male employees
involved in PVC plastic production. Although exposed workers could
demonstrate greater levels of biomarkers of exposure compared to con-
trol groups, when included, non-definite and homogeneous conclusions
could be obtained from all the revised studies in this regard.
Interestingly, some studies also addressed some possible biomarkers of
effect related to occupational exposure to phthalates. These aspects will
be discussed in greater detail in the following paragraphs.
Most of the occupational HBM studies were on “old” phthalates, with
the majority of the reviewed data coming from the plastics sector.
However, one of the obvious data gaps relates to the shortage of occu-
pational exposure studies on the phthalates currently used in the industry
(e.g., DiNP, DiDP, DPHP). Few studies assess DiNP exposure, and only 2
of them analyze the secondary metabolites of DiNP (Hines et al., 2012;
Koch et al. 2012b). The other investigations only dealt with the primary
metabolite MiNP, which is known to be an inappropriate marker of DINP
exposure (Hines et al., 2012). Regarding the other phthalates currently in
use, only one study evaluated occupational DiDP/DPHP exposure using a
method that could not differentiate the two phthalates (Koch et al.
2012b). It should be noted that in this study, the workers in a car
manufacturing plant in Germany were exposed to DiNP-based plastisol,
which may also contain other high molecular weight phthalates like
DiDP and DPHP. To our knowledge, no single occupational study on
workers directly exposed to DiDP or DPHP has been published in inter-
national journals. However, at least one national report on small-scale
occupational DPHP exposure was identified (Porras et al., 2016).
Nevertheless, it is still useful to monitor old phthalates in some sectors.
The use of older phthalates (restricted under REACH) may still be au-
thorized in special applications falling under different regulatory frame-
works. Even if the EU published regulations in 2018 to expand the number
of restricted phthalates from 3 (DEHP, DBP, and BBP) to 4 (DEHP, DBP,
BBP, and DIBP), the new legislation exempts certain categories of articles
from this restriction. Thus, specific uses of these phthalates such as ex-
clusively industrial, agricultural, or open air applications in which there is
no direct contact, or their usage in specific articles for motor vehicle/
aircraft repair or maintenance may be still permitted despite their re-
striction at the EU level. The same applies to food contact materials and
medical packaging as well as uses for medical or measuring devices cov-
ered by other legislation. However, because most DEHP and other older
phthalates have been replaced by newer ones, occupational exposure to
them is nowadays expected to occur through waste management and re-
cycling. In this respect, there is also a data gap, because only a single study
from China includes urinary MEHHP and MEOHP concentrations of waste
plastic recycling workers (Wang et al., 2018) (Table 3). In another in-
vestigation analyzing MEHP, waste management workers in Slovakia were
studied (Kolena et al., 2014). Urinary MEHP has a significant con-
tamination risk, and thus, HBM data based on MEHP should be taken into
account with caution. In this study, waste management workers were
exposed to a range of phthalates, and when comparing workers with the
general population, a higher concentration of MEHP was observed in
workers’ urine (median 5.94 μg/L; 95th percentile 60.71 μg/L; Kolena
et al., 2014). However, as plastic waste is also used as construction ma-
terial, there is still an open question as to whether old phthalates may once
again be present in working environments. For the use of phthalates in-
cluded in Annex XIV of REACH for recycled plastics, authorization is
needed. Currently, there is one (transient) authorization granted for the
use of DEHP in recycled plastics for specific purposes (ECHA, 2019). Thus,
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it would seem that in the waste management setting, it is still relevant to
collect more data due to the increasing reuse of plastic materials boosted
by the circular economy.
There is a large variability in phthalate concentrations between stu-
dies and across sectors, up to 13-fold when comparing extreme GMs of
MEHHP, a metabolite of DEHP and one of the most widespread phthalate
plasticizers (Table 3). This can be mostly explained by differences in the
processes, operating conditions, and risk management methods resulting
in variable occupational exposures, although some variations may also
be caused by worker variability, short biomarker half-lives, and differ-
ences in sampling strategies and analytical techniques. In addition, the
comparison of these results (GM of MEHHP generally 25–50 μg/g cr, but
observed up to 151 μg/g cr) with those observed in the general popu-
lation shows that workers are more highly exposed overall (GM of
MEHHP in adults: 12.2 μg/g cr in France in 2014–2016, SpFrance, 2019;
13.1 μg/g cr in 2010, 6.1 μg/g cr in 2014, and 5.4 in 2016 in the USA,
CDC, 2019; about 12 μg/g cr in Canada in 2009–2011, Health Canada,
2013). Given the various time trends in phthalate usage in the different
countries and thus the varying background exposure of the general po-
pulation, one must be cautious when occupational exposure data are
compared to those of the general population. In occupational exposure
studies, it is advisable to have a separate control group of non-occupa-
tionally exposed workers from the same area (or at least from the same
country), and the sample collection should be done in the same manner
as that of workers. If this is not possible, general population data could be
used by matching the sample collection location and date as closely as
possible to those of occupationally exposed workers.
Another issue to be considered is the origin of the phthalate studies.
Taking DEHP as an example, 47% were from Europe, with the others
originating from China, Korea, and the USA. If we consider only
MEHHP studies, 5 were from Europe (1 from Germany and 4 from
Slovakia), but they dealt with 4 different work tasks (Table 3). In ad-
dition, these studies included limitations in terms of sample size
(German study) or sampling time (Slovakian studies). Taking this into
account, together with the almost complete lack of data for newer
phthalates, it is evident that the insufficient data available in European
countries prevents us from drawing any far-reaching conclusions about
the level and regional clustering of phthalate exposure in Europe.
The occupational exposure studies frequently report data for more than
one phthalate, suggesting that in many cases, there may be occupational
exposure to phthalate mixtures. However, this depends on the industrial
sector and their use of many different phthalates (e.g., in plastics manu-
facturing), or only 1 or 2. This occupational exposure adds to the body burden
from the living environment, consumer products, and food (Serrano et al.,
2014). This is why combining environmental and occupational exposures is
useful when estimating associated health risks, especially in the case of en-
docrine disruptors, which may express biological effects at low doses.
Additionally, only a few studies included a non-occupationally ex-
posed control group in the experimental design, but in some cases,
possible workplace exposure could not be excluded for such reference
groups, thus preventing the extrapolation of definite conclusions about
their occupational contact (Lu et al., 2014; Pan et al., 2006). Con-
cerning the timing of biological monitoring sampling, in some cases, it
was not always appropriate for the studied biomarkers: for example,
when performed the morning after a workday or as a spot sample
collection during the shift (Kolena et al., 2014, 2017; 2019; Petrovicova
et al., 2014, 2016; Pilka et al., 2015). In some studies, no pre-shift
samples were collected (Huang et al., 2014; Lu et al., 2014). This may
suggest the need for a standardized approach to biological sampling in
order to extrapolate more suitable data for comparison.
This review shows that there are only a few occupational HBM stu-
dies available on the potential endocrine-disrupting effects of phthalates.
They report associations between phthalate metabolite levels and hor-
mone levels or sperm quality in occupational populations (Fong et al.,
2015; Huang et al., 2014; Pan et al., 2006; Wang et al., 2018). However,
occupational data on these effects are currently very limited and include
different confounders. Therefore, further studies are needed to explore
these associations in occupational populations that are possibly exposed
to high phthalate levels. There is a concern about the potential trans-
generational effect of phthalates. In an environmental exposure study, it
was shown that the fetus is transplacentally exposed to higher levels of
MBP than the mother (Kolatorova et al., 2018). Also, effects on fetal
steroidogenesis have been proposed. It was further suggested that
transplacental exposure to phthalates is associated with methylation
changes in several genes involved in the control of spermatogenesis,
testes development, inflammatory response, and even cancer and in-
fertility (Solomon et al., 2017). Concerning occupational exposure, there
is a lack of published reports dealing with exposure to phthalates and
transplacental effects. The other health effects of phthalates have been
studied among workers, such as alterations in pulmonary function
parameters or anthropometric parameters, but these studies are very
limited. The scientific literature on toxicology and general population
studies is much more abundant and offers a broader overview of the
potential health effects of phthalates (Lymperi and Giwercman, 2018).
Based on this review, it is easy to appreciate that the available data
do not report the occupational settings susceptible to phthalate ex-
posure such as the exposures to newer phthalates in the production of
different products (e.g., waterproof gloves, tablecloths, shower cur-
tains, floor tiles, toys, blood bags, beer bottle caps), where DEHP was
commonly used in the past (Alexander and Baxter, 2014; Van Tongeren
et al., 2002). Moreover, occupational settings such as waste manage-
ment and recycling are of relevance for future research (Muenhor et al.,
2018), as well as the construction sector in which exposure to phtha-
lates may occur through floorings, for example (Fucic et al., 2018).
Combining biomonitoring data with relevant contextual information
(work tasks, operational conditions, risk management measures in place,
etc.) allows us to understand the most important exposure route and
workplace conditions that influence exposure and, consequently, identify
the type of interventions that are still needed to prevent exposure.
Unfortunately, contextual information is missing in most of the studies
reviewed here; it should therefore be collected in future studies. The use of
validated, sensitive, and accurate analytical methods to measure trace
concentrations of phthalate metabolites in humans is also essential for as-
sessing exposure to phthalates. The analysis of phthalate metabolites fol-
lows a typical procedure for organic contaminants, namely sample pre-
treatment, extraction and cleanup, concentration and re-constitution in a
suitable solvent, separation by chromatography, and detection by mass
spectrometry (Kumar and Sivaperumal, 2016). The LOD (and LOQ) of
phthalate metabolites used in the occupational HBM studies should be low
enough to compare results across different population subgroups and
countries and between occupational HBM studies and national HBM stu-
dies in the general population (SpFrance, 2019; CDC, 2019; Koch et al.,
2017; Health Canada, 2013).
5. Conclusion
Overall, our findings indicate that there is a lack of recent occupa-
tional HBM studies in European countries, and considering the important
policy actions taken in Europe, it seems relevant to evaluate the impact
of these actions on workers’ exposure. To compare such data, a harmo-
nized approach for sample collection and analysis is needed.
Furthermore, most of the studies are still dedicated to “old” phthalates
(already with regulatory/policy actions in place in the EU) as opposed to
the currently used “newer” phthalates that have substituted them. Future
occupational HBM studies should therefore include exposure to newer
phthalates in the production of various plastic products, but also the
waste management, recycling, and construction sectors. Combining
biomonitoring data with the description of work tasks, operational con-
ditions, and workplace characteristics would further support future in-
terventions to reduce exposures.
New biomonitoring studies should focus on occupational settings
where exposure is expected to include a large number of workers, and
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in addition to the old phthalates (for comparative purposes), newer
phthalates should also be included in the biomonitoring studies. This
new biomonitoring data will result in evidence that can be used to
prioritize actions and measures for policymaking, evaluate the effec-
tiveness of the policy measures already taken, and promote more
comprehensive health impact assessments of policy options (Ganzleben
et al., 2017).
Additionally, depending on the selection of target populations and
their exposure, the inclusion of appropriate effect biomarkers such as
hormone levels (e.g., estrogen, testosterone, thyroid hormones), sperm
quality, or information on infertility and transplacental effect of phtha-
lates could be considered and interpreted while paying attention to
participants’ age groups and sex as well as other potential confounders.
Since reliable biomonitoring methods exist for many commonly
used phthalates, the biomonitoring of phthalates should be considered
in workplaces given the potential phthalate exposure and be recognized
not only as an important health surveillance tool but also as a relevant
exposure assessment resource to be used in risk assessment and man-
agement. With the HBM4EU project (www.hbm4eu.eu), EU-wide re-
ference values and biomonitoring guidance values will be developed to
be used in the interpretation of biomonitoring results.
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